Bitcoin Updates: Amid Bitcoin’s Plunge, Saylor’s Company Amasses $835M, Bucking the Market Sell-Off
- Michael Saylor's Strategy Inc. bought 8,178 BTC ($835.6M) despite Bitcoin's 25% drop, boosting holdings to 649,870 BTC ($61.7B). - The purchase, funded by perpetual preferred stock sales, reflects confidence in Bitcoin's long-term value despite market selloffs and ETF outflows. - Saylor's firm maintains a conservative leverage ratio (8B debt vs. 61B BTC) and claims resilience against multi-year price collapses. - Institutional Bitcoin adoption persists as Harvard allocates $443M to crypto ETFs, though St
Michael Saylor's Bitcoin-Focused Company
Michael Saylor’s enterprise, Strategy Inc. (previously MicroStrategy), has reiterated its dedication to
This acquisition comes during a broader market downturn, as Bitcoin ETFs have seen notable outflows. On November 13, U.S. spot Bitcoin ETFs recorded $866.7 million in net withdrawals—their second-largest single-day outflow since launching in January 2024.
Despite these conditions, Strategy’s approach remains focused on long-term Bitcoin accumulation. The latest purchases were made under its “42/42” capital plan, which aims to raise $84 billion in equity and convertible notes by 2027. This includes $21 billion through ATM programs for its STRK perpetual preferred shares and other financial instruments.
The company’s financial strength is further demonstrated by its market net asset value (mNAV) ratio, which
Institutional faith in Bitcoin’s prospects is also apparent elsewhere in the market.
Despite ongoing turbulence, Saylor remains optimistic, arguing that Bitcoin’s limited supply and increasing institutional interest will support its long-term value. “The fundamentals are strong,” he stated, reiterating his belief that shareholders could endure a 90% price decline over four to five years
As the crypto sector faces ongoing macroeconomic headwinds, Strategy’s bold accumulation and Saylor’s steadfast belief act as a gauge for institutional Bitcoin adoption. Whether this approach proves robust or susceptible to further declines will hinge on Bitcoin’s price movement and the broader risk appetite in financial markets.
---
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Updates: ETF Withdrawals and Rising Short Positions Push Bitcoin Below Bearish Threshold
- Bitcoin fell below the 0.75 cost basis quantile, a key bear-market threshold identified by Glassnode, signaling renewed downward pressure. - ETF outflows surged $866.7M on November 13, with BlackRock's IBIT and Grayscale's Bitcoin Mini Trust leading redemptions amid $100,000 price drop. - Harvard's $443M IBIT investment contrasts with bearish technical signals like the "death cross," while Nansen tracks $5.7M in new short positions. - Tight futures liquidity and 46% Fed rate-cut probability amplify downs
Bitcoin Updates Today: Is Crypto's Death Cross Indicating a Recovery or Warning of a Downturn?
- Cryptocurrency markets face selloff as Bitcoin , Ethereum , and XRP decline amid a "death cross" signal and waning institutional demand. - Technical analysis highlights Bitcoin's 50-day moving average nearing the 200-day line, historically linked to prolonged downturns or potential rebounds. - Blockchain data reveals $953M BTC moved from Mt. Gox wallets, triggering $1B in forced liquidations despite analysts labeling the transfers administrative. - Historical death crosses have preceded market bottoms, b
Aster News Today: DeFi Competition Heats Up: Incentivizing Liquidations to Draw in Traders
- Aster, a decentralized crypto exchange, launched "Machi mode" to reward traders with points for liquidations, embracing risk-taking culture. - Competitor Hyperliquid slashed taker fees by 90% via HIP-3 "growth mode," targeting liquidity providers and challenging centralized exchanges. - Both strategies reflect DeFi's arms race to attract traders through gamification (Aster) and technical efficiency (Hyperliquid), blurring financial utility with community identity. - Traders praised Aster's "failure-as-fe
Olema’s Proposal Dampens Hopes for Trial, Sparks Decline Due to Dilution Concerns
- Olema Pharmaceuticals (OLMA) shares fell 6.9-7.2% post-announcement of a stock and warrant offering, triggering dilution concerns among investors. - The TD Cowen-led offering includes a 30-day greenshoe option for up to 15% additional shares, with proceeds intended to fund breast cancer therapies like palazestrant (Phase 3) and OP-3136 (Phase 1). - Despite recent 81% stock gains and positive SERD trial data from Roche, the offering overshadowed optimism, though analysts at H.C. Wainwright and Guggenheim
